MedTrace Logo

Anodyne Therapy in Diabetic Sensory Neuropathy

NCT00120341 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-06-01

No results posted yet for this study

Summary

The purpose of this research study is to determine if the use of a series of the Anodyne Therapy System in-home treatments over a 90-day period will improve peripheral sensation and quality of life in persons with diabetes mellitus.

Conditions

Interventions

DEVICE

Anodyne Therapy System

Sponsors & Collaborators

  • Anodyne Therapy, LLC

    collaborator INDUSTRY

  • Scott and White Hospital & Clinic

    lead OTHER

Principal Investigators

  • Lawrence A Lavery, DPM · Scott and White Memorial Hospital & Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Completion
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00120341 on ClinicalTrials.gov